Christopher H. Rassekh, MD is Professor of Clinical Otorhinolaryngology-Head and Neck Surgery at Penn Medicine. He is the Director of the Penn Medicine Sialendoscopy Program, which provides evaluation of and minimally invasive surgery for diseases that cause swelling of the salivary glands including obstructive diseases such as salivary stones, salivary duct strictures and tumors. As a trusted member of the international salivary gland care community, he will serve as co-chair for the 5th International Salivary Gland Congress held at Penn Medicine in October of 2019. Dr. Rassekh sees patients with head and neck tumors including cancers of the mouth, throat, voice box, salivary gland, thyroid and neck and also was a very early adopter of Transoral Robotic Surgery (TORS) for tumors and salivary gland diseases, and is an expert in cranial base surgery. He also is co-chair of the Airway Safety Committee at the Hospital of the University of Pennsylvania.
Dr. Rassekh has been very active in the national and international community including the American Academy of Otorhinolaryngology which awarded him the Distinguished service award in 2007. He has been on the board of directors of the North American Skull Base Society and served on numerous committees in that organization. He is currently on the Board for the Salivary Section of the American Head and Neck Society and has been on the program planning committee for all three of these organizations. He is a fellow of the Triological Society (aka Laryngological, Otological and Rhinological Society).
Recognized by America's Top Doctors, 2012 - 2018
Recognized by Best Doctors in America 2015 - 2018
Recognized in Philadelphia magazine's annual Top Docs issues, 2018 - 2021
Specializing in Head and Neck Cancer, tumors, salivary gland diseases, sialendoscopy, and all other aspects of Otolaryngology-Head and Neck Surgery, especially diseases of the nose, throat and neck and skull base.